KIKK Capital

KIKK Capital is a venture capital firm based in Roosendaal, Netherlands, founded in 2016. The firm focuses on investing in young companies that have recently developed and launched innovative products, processes, or services. KIKK Capital not only provides financial support but also contributes valuable expertise, skills, and network connections to help these start-ups succeed. The firm primarily targets investments in Netherlands-based start-ups, fostering growth and development within the local entrepreneurial ecosystem.

Fatih Kaya

Finance and Investment Professional and Investment Manager

Johan Sebregts

Founder and Managing Partner

Jan Theunissen

Senior Investment Manager

Bas Van Berkum

Investment Manager

5 past transactions

Chromodynamics

Seed Round in 2024
Chromodynamics is a deep tech company creating a range of multispectral cameras that can take photos of the composition of materials in real time.

Secret View

Series A in 2022
Secret View operates a market research agency focused on enhancing business customer experience. It offers an affordable system for organizations to continually learn from real customer experiences via mystery shopping research, enabling retail and hospitality chains to measure and improve customer experience.

River BioMedics

Seed Round in 2022
River BioMedics is a biotech company developing 3D human cardiac tissue models for preclinical drug discovery and toxicity screening. These tissues mimic the structure and function of the human heart and provide clinically relevant readouts to assess a compound's effects on cardiac performance and safety. The company uses a stem cell-based, multidisciplinary approach to generate models that support target validation and the discovery and development of novel cardiac therapies.

Pepscope

Venture Round in 2020
Pepscope is a Dutch biotechnology company that develops endogenous protein kinase activity profiling technologies, including QuantaKinome, a platform used by pharmaceutical companies and academic researchers to study kinase activity and support the discovery and development of kinase inhibitors and other therapies. The company focuses on profiling protein activity to reveal new applications for existing compounds and to guide therapy development. Its offerings span microarray- and mass spectrometry-based proteomics services and kinase profiling assays, enabling reproducible results and robust longitudinal studies. Founded in 2012 and based in Nijmegen, Pepscope aims to provide actionable proteomics insights to the pharmaceutical industry and researchers.

Toxys

Venture Round in 2020
Toxys is a Dutch biotech company offering innovative in vitro toxicity screening solutions. It rapidly identifies hazardous and potential carcinogenic properties of novel compounds during early product and drug development phases, enabling informed decisions to advance safer medicines while reducing animal testing.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.